You are here

Xinmeng Jasmine Mu


Giannakis M, Mu XJ, Shukla SA, et al. Genomic correlates of immune cell infiltrates in colorectal carcinoma. Cell Rep. 2016;15;857–865.

Giannakis M, Hodis E, Mu XJ, et al. RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet. 2014;46;1264–1266.

Khurana E, Fu Y, Colonna V, Mu XJ, et al. Integrative annotation of variants from 1,092 humans: application to cancer genomics. Science 2013;342:1235587.

Xinmeng Jasmine Mu, Ph.D.

Xinmeng Jasmine Mu is a computational biologist in the Cancer Program at the Broad Institute of MIT and Harvard working under the direction of Levi Garraway in association with the Dana-Farber Cancer Institute and Brigham and Women’s Hospital. She studies genomic alterations in cancer to elucidate tumor heterogeneity and drug resistance and undertakes computational modeling of cancer molecular epidemiology data. A key focus of recent work has been studying genomic correlates of immune cell infiltration from an epidemiological cohort in colorectal cancer.

Mu has experience in bioinformatics and computational genomics research, next-generation sequencing project design and data analyses, clinical sequencing and analyses in cancer genomics, molecular cancer epidemiology modeling, population genomics and evolutionary force characterization, networks analyses, machine learning, and multivariate statistical analyses, among others.

Prior to joining the Broad Institute in 2013, Mu studied human genomic evolution in the Mark Gerstein group at Yale University for her Ph.D. in computational biology and bioinformatics. She also holds an M.S. in molecular, cellular, and developmental biology from Yale, as well as a B.S. in biological science from Peking University.

Contact Xinmeng Jasmine Mu via email at

June 2016